#RNL2024 @RheumNow @DrDavidKarp Incomplete lupus is heterogeneous term "Stage 2" pre-classification stage as ILE/UCTD Stage 1: non-specific antibodies, dysregulation 2: incomplete features 3: classified, multi-system disease 4: irreversible tissue damage https://t.co/CuLUzSZ24E

@reumacia @RheumNow You are absolutely right. The point was not generally used for psoriasis ( not PsA). I was surprised my self 🤕. Here is the slide again by Dr. Armstrong , great talk by the way. Let me know if you want the handout. https://t.co/C11Gkn2jho

Appreciative inquiry in rheumatology and how to enhance and improve our clinical notes to frame our encounter in a positive manner. @BharatKumarMD #RNL2024 @RheumNow https://t.co/iTXwjUb6tg

Some takeways from JAK inhibitors in dermatology talk by Bruce Strober. Great talk. #RNL2024 @RheumNow https://t.co/fuRsSnnsha

Alopecia aerate and JAK Bruce Strober #RNL2024 @RheumNow https://t.co/lGig1Vpf5x

Examples from the world of dermatology on JAK inhibitor success stories. Bruce storber. #RNL2024 @RheumNow https://t.co/S01lEIqjbR

Dermatology colleagues are using JAKis with success for wide range of dermatological diseases. Note the beauty of this slide with further elaboration on domain inhibition, cool stuff 🤓 Bruce Strober #RNL2024 @RheumNow https://t.co/2yHHcOgTC8

Allosteric versus active site inhibition by JAK. Never understood this better. Thanks to Bruce Strober. #RNL2024 @RheumNow https://t.co/r9hhHLO5oS

JAK safety and malignancy risk. Great talk by kevin Winthrop. #RNL2024 @RheumNow https://t.co/d7WRHJxrpM

@BharatKumarMD at #RNL2024 @RheumNow Appreciative Inquiry in Rheumatology 5(ish) steps Dawn (what focus on) -> Discovery (what gives life) -> Dream (what might be) -> Design (what should be) -> Destiny (how can i execute) -> New Dawn - Empathy at center of inquiry https://t.co/gDhXpi94pT

JAK toxicity of interest. Eric Ruderman #RNL2024 @RheumNow https://t.co/qdlJFKTUR8

Unique and selective allosteric mechanism of deucravacitinib. Eric Ruderman #RNL2024 @RheumNow https://t.co/Zm3bYGR9JJ